Sort
82,697 grants matching “vaccine development”
EXTRAMURAL RESEARCH FACILITIES IMPROVEMENT PROVEMENT
$3,600,000University Of Maryland Baltimore · C06 · FY2003 · RR
Infectious Diseases Research Technologies Core - RML
$3,599,299Robert Hohman · National Institute Of Allergy And Infectious Diseases · ZIC · FY2013 · AI
NIAID Centers of Excellence for Influenza Research and Response (CEIRR): Universal Influenza Vaccine Research Activities
$3,599,265Scott Hensley · University Of Pennsylvania · N01 · FY2025 · AI
FEASIBILITY STUDY OF A PROSPECTIVE COHORT OF HIV & ZIKA IN INFANTS AND PREGNANCY (HIV-ZIP)
$3,595,918Barbara Driver · Westat, Inc. · N01 · FY2018 · HD
DEVELOPMENT OF TECHNOLOGIES THAT ACCELERATE THE IMMUNE RESPONSE TO BIODEFENSE VACCINES
$3,593,334Paul Chaplin · Bavarian Nordic A/S · N01 · FY2014 · AI
IMMUNE MECHANISMS OF PROTECTION AGAINST MYCOBACTERIUM TUBERCULOSIS CENTER
$3,592,425Kevin Urdahl · Seattle Children'S Hospital · N01 · FY2023 · AI
NIAID SPECIMEN REPOSITORY
$3,592,175Deborah Phippard · Precision Bioservices, Inc. · N01 · FY2019 · AI
RFA-GH-19-004, Advancing Public Health Research in Bangladesh
$3,588,493Sayera Banu · International Ctr/Diarrhoeal Dis Res · U01 · FY2023 · GH
Biomedical Product Assessment
$3,587,248Jason Gall · National Institute Of Allergy And Infectious Diseases · ZIB · FY2025 · AI
Adolescent Trials Network for HIV/AIDS Intervention
$3,586,264Westat, Inc. · U01 · FY2004 · HD
China's Integrated Programs for Research on AIDS
$3,585,868National Center/Aids/Std Control/Prevent · U19 · FY2003 · AI
UCLA AIDS Prevention and Treatment Clinical Trials Unit
$3,585,709Raphael J Landovitz · University Of California Los Angeles · UM1 · FY2025 · AI
Novel Ad/MVA and Ad/Protein HIV-1 Vaccines
$3,585,085Dan H. Barouch · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
Adjuvant development in the context of seasonal and pandemic influenza
$3,583,801Jay Evans · University Of Montana · N01 · FY2021 · AI
University of Washington/Fred Hutch Center for AIDS Research
$3,581,608Connie L Celum · University Of Washington · P30 · FY2024 · AI
National AIDS Research Institute (NARI), Pune, INDIA: Clinical Trials Unit
$3,581,399Sanjay M Mehendale · National Aids Research Institute · U01 · FY2008 · AI
DEVELOPMENT OF TUBERCULOSIS VACCINE FORMULATIONS
$3,581,021Chris Fox · Access To Advanced Health Institute · N01 · FY2014 · AI
Strategies for Cancer Immunotherapy Development: Preclinical Studies
$3,580,727Jeffrey Schlom · Division Of Basic Sciences - Nci · ZIA · FY2025 · CA
RCMI Center for Health Disparities Research
$3,580,236Deepak Kumar · North Carolina Central University · U54 · FY2024 · MD
Alphavirus Replicon Vaccines against Botulinum Neurotox*
$3,577,242Alphavax Human Vaccines, Inc. · U01 · FY2004 · AI
Case AIDS Clinical Trials Unit
$3,573,700Michael Marcel Lederman · Case Western Reserve University · U01 · FY2010 · AI
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2018 · CA
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2015 · CA
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2016 · CA
Cancer Center Support (Core) Grant
$3,572,644Tyler E Jacks · Massachusetts Institute Of Technology · P30 · FY2017 · CA